Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations)
The World Health Organization has identified a group of diseases that are the world's most pressing health problems. This represents an opportunity for test manufacturers, particularly in POC testing. Because of their ability to deliver fast results at the point of care, rapid testing is a focus area of healthcare providers and payors in infectious disease prevention. Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with fastest growth, and infectious disease has surfaced as one of those segments.
This report, Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations), examines this POC segment with a focus on new threats for which there are markets in the developing world and in developed countries.
A Unique Approach: Market and Technical Analysis
Tests can only be marketed if they can be manufactured and if they can function in the healthcare environment. Thus, this report also discusses the technical choices, possibilities and limitations to today's POC tests especially when they are used in the developing world. Reagent issues, testing on strips, instrumented and non-instrumented tests are coved in this report. These factors will impact what tests will reach the market and how they will function.
Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with fastest growth, and infectious disease has surfaced as one of those segments. This report, Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations), examines this segment, and especially new threats for which there are large markets in the developing world and in developed countries.
An Opportunity For Test Makers
Infectious disease is a broad category, and in some disease areas, diagnostic companies already own market share. Increasingly hospitals and clinics are seeing new infectious disease threats and tests are being developed to assist them. Within the infectious disease testing market, this report details the opportunities that could be found when diseases of the developing world enter the healthcare system of the developed.
This report, Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations), examines this POC segment with a focus on new threats for which there are markets in the developing world and in developed countries.
A Unique Approach: Market and Technical Analysis
Tests can only be marketed if they can be manufactured and if they can function in the healthcare environment. Thus, this report also discusses the technical choices, possibilities and limitations to today's POC tests especially when they are used in the developing world. Reagent issues, testing on strips, instrumented and non-instrumented tests are coved in this report. These factors will impact what tests will reach the market and how they will function.
Kalorama Information has been reporting on the rapid test area for several years and has identified the segments with fastest growth, and infectious disease has surfaced as one of those segments. This report, Point of Care Diagnostics for Emerging Infectious Disease Threats (Market Analysis and Technical Considerations), examines this segment, and especially new threats for which there are large markets in the developing world and in developed countries.
An Opportunity For Test Makers
Infectious disease is a broad category, and in some disease areas, diagnostic companies already own market share. Increasingly hospitals and clinics are seeing new infectious disease threats and tests are being developed to assist them. Within the infectious disease testing market, this report details the opportunities that could be found when diseases of the developing world enter the healthcare system of the developed.
CHAPTER ONE: EXECUTIVE SUMMARY
Scope and Methodology
Emerging Market Trends, diseases and technologies
World Demand for Decentralized Testing for Infectious Diseases
CHAPTER TWO: COMMERCIALIZATION OF DECENTRALIZED TEST DEVICES FOR INFECTIOUS DISEASES
Overview
User Training and Support Services
Connectivity Supports Decentralized Testing
The Disease Burden
Drug Resistance Complicates the Test Landscape
An Unmet Need
Economics of Financial and International Programs
Conclusion
CHAPTER THREE: TECHNICAL CONSIDERATIONS
Overview
Reagent Issues
Instrumented or non-instrumented
Diagnostics on Paper Test Strips
The Promise of Decentralized Molecular Diagnostics
Wireless Communication
Miniaturization
CHAPTER FOUR: CHAGAS DISEASE
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER FIVE: CHIKUNGUNYA
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER SIX: DENGUE
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER SEVEN: HIV
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER EIGHT: HPV
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER NINE: LEISHMANIASIS
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER TEN: LEPTOSPIROSIS
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER ELEVEN: MALARIA
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER TWELVE: ONCHOCERCIASIS (RIVER BLINDNESS)
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER THIRTEEN: STDs
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER FOURTEEN: TUBERCULOSIS
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
Scope and Methodology
Emerging Market Trends, diseases and technologies
World Demand for Decentralized Testing for Infectious Diseases
CHAPTER TWO: COMMERCIALIZATION OF DECENTRALIZED TEST DEVICES FOR INFECTIOUS DISEASES
Overview
User Training and Support Services
Connectivity Supports Decentralized Testing
The Disease Burden
Drug Resistance Complicates the Test Landscape
An Unmet Need
Economics of Financial and International Programs
Conclusion
CHAPTER THREE: TECHNICAL CONSIDERATIONS
Overview
Reagent Issues
Instrumented or non-instrumented
Diagnostics on Paper Test Strips
The Promise of Decentralized Molecular Diagnostics
Wireless Communication
Miniaturization
CHAPTER FOUR: CHAGAS DISEASE
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER FIVE: CHIKUNGUNYA
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER SIX: DENGUE
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER SEVEN: HIV
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER EIGHT: HPV
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER NINE: LEISHMANIASIS
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER TEN: LEPTOSPIROSIS
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER ELEVEN: MALARIA
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER TWELVE: ONCHOCERCIASIS (RIVER BLINDNESS)
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER THIRTEEN: STDs
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
CHAPTER FOURTEEN: TUBERCULOSIS
Introduction: Key Comment
Geographic Markets
International Programs
Status quo in testing
Players
Test technologies, now and future
